Research Article
Novel Synthetic Coumarin-Chalcone Derivative (E)-3-(3-(4-(Dimethylamino)Phenyl)Acryloyl)-4-Hydroxy-2H-Chromen-2-One Activates CREB-Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer’s Disease
Figure 7
LM-021-mediated kinase activation in ΔK280 tauRD-DsRed-expressing SH-SY5Y cells. (a) Experimental flow chart. On day 1, cells were plated with retinoic acid (RA, 10 μM) being added to the culture medium. On day 2, LM-021 (10 μM) was added to the cells for 8 h, followed by adding doxycycline (Dox, 2 μg/ml) to induce ΔK280 tauRD-DsRed expression. Kinase inhibitors (10 μM) were added to the cells on day 6. On day 8, p-PKA, p-CaMKII, p-ERK, p-CREB, BDNF, BCL, and BAX levels, as well as neurite outgrowth (TUBB3 staining), were measured. (b) p-PKA, p-CaMKII, and p-ERK protein levels determined by immunoblot using GAPDH as a loading control (). To normalize, the protein expression level in untreated cells was set as 100%. (c) Measurements of neurite outgrowth (length, process, and branch) (). values: induced vs. uninduced cells (## and ###), LM-021-treated vs. untreated cells ( and ), or kinase inhibitor-treated vs. untreated cells (&, &&, and &&&) (one-way ANOVA with a post hoc Tukey test).
| (a) |
| (b) |
| (c) |